Craft
Terumo

Terumo

Revenue

¥703.3 B

FY, 2022

Market Capitalization

¥2.9 T

2023-01-23

Terumo Summary

Company summary

Overview
Terumo is a manufacturer of medical devices and supplies. It offers pharmaceuticals, blood bags, disposable medical devices, cardiovascular systems, vascular grafts, peritoneal dialysis, blood glucose monitoring system, medical electronic, and digital thermometers.
Type
Public
Status
Active
Founded
1921
HQ
Tokyo, JP | view all locations
Website
https://www.terumo.com
Cybersecurity rating
ESG rating
60-79 out of 100|View all ESG data
Sectors

Key people

  • Shinjiro Sato

    Shinjiro Sato, President and CEO

    • Toshiaki Takagi

      Toshiaki Takagi, Director and Senior Managing Executive Officer

      • Shoji Hatano

        Shoji Hatano, Director and Managing Executive Officer

        • Kyo Nishikawa

          Kyo Nishikawa, Director and Managing Executive Officer

          LocationsView all

          65 locations detected

          • Tokyo, Tokyo HQ

            Japan

            2-44-1 Hatagaya Shibuya-ku

          • Aliso Viejo, CA

            United States

            35 Enterprise

          • Ann Arbor, MI

            United States

            6200 Jackson Rd

          • Coral Gables, FL

            United States

            121 Alhambra Plaza STE 1120

          • Franklin Township, NJ

            United States

            265 Davidson Ave #320, Somerset

          • Lakewood, CO

            United States

            10810 Collins Ave

          and 59 others

          Terumo Financials

          Summary financials

          Revenue (Q2, 2023)
          ¥206.0B
          Gross profit (Q2, 2023)
          ¥124.5B
          Net income (Q2, 2023)
          ¥17.9B
          Cash (Q2, 2023)
          ¥212.6B
          EBIT (Q2, 2023)
          ¥25.3B
          Enterprise value
          $2.9T

          Footer menu